Clinical Trials Browser

Interventional × Glioblastoma × TH 302 × Clear all

NCT02342379 2020-04-10

TH-302 in Combination With Bevacizumab for Glioblastoma

Phase 2 Completed

35 enrolled 6 charts

Glioblastoma